A luciferase reporter gene assay was used to investigate for functional implications of sequence variation between zebrafish Pxr variants. For this, two putative zebrafish Pxr in vitro agonists were used, a local anesthetic (4BAB) and an antifungal drug (CLO). Immunoblotting using anti-GAL4 antibodies demonstrated that the levels of the zfPxr variants were similar in the COS7 cells (Supplementary Figure 6). CLO increased luciferase activities by approximately 23–34 million RLUs in cells expressing PxrAB/Tü, PxrTL, and PxrSWT, whereas Rmax in cells expressing PxrUNK was approximately 1.8 million RLUs (Figure 2A, Tables 3 and 4). Butyl-4-aminobenzoate induced a moderate increase in the luciferase activities in cells expressing PxrAB/Tü, PxrTL, or PxrSWT (ΔRLUs in the range of 2.8–6.3 million), whereas luciferase activity in cells expressing PxrUNK did not increase (Figure 2B, Tables 3 and 4).

Table 3.

Dose-Response Dynamics for Activation of Allelic Variants of Zebrafish Pxr by CLO and 4BAB and Ligand-Receptor Interaction

Zebrafish Pxr VariantClotrimazole (CLO)
Butyl 4-Aminobenzoate (4BAB)
Rmax (e6 ΔRLU±SD)EC50 (e−7 M)Dissociation Constant (Kd) (μM)Rmax (e6 ΔRLU±SD)EC50 (e−5 M)
PxrAB/Tü22.6 ± 0.28 (b, c, d, *)1.42 (b, c, d, *)0.042.75 ± 1.65 (c, *)0.96 (b, c, *)
PxrTL34.0 ± 5.75 (a, d, *)1.08 (d, *)4.14.57 ± 2.41 (*)1.16 (a, *)
PxrSWT28.5 ± 6.80 (a, d, *)1.28 (a, *)2606.31 ± 2.86 (a, *)1.18 (a, *)
PxrUNK1.81 ± 0.67 (a, b, c)3.48 (a, b)180N/DN/D
Zebrafish Pxr VariantClotrimazole (CLO)
Butyl 4-Aminobenzoate (4BAB)
Rmax (e6 ΔRLU±SD)EC50 (e−7 M)Dissociation Constant (Kd) (μM)Rmax (e6 ΔRLU±SD)EC50 (e−5 M)
PxrAB/Tü22.6 ± 0.28 (b, c, d, *)1.42 (b, c, d, *)0.042.75 ± 1.65 (c, *)0.96 (b, c, *)
PxrTL34.0 ± 5.75 (a, d, *)1.08 (d, *)4.14.57 ± 2.41 (*)1.16 (a, *)
PxrSWT28.5 ± 6.80 (a, d, *)1.28 (a, *)2606.31 ± 2.86 (a, *)1.18 (a, *)
PxrUNK1.81 ± 0.67 (a, b, c)3.48 (a, b)180N/DN/D

Maximum response (Rmax) and effective concentration 50 (EC50) of Pxr-mediated induction of luciferase activities in COS7 cells calculated from dose-response curves fitted by nonlinear regression (GraphPad Prism 7.0). Dissociation constants were determined from experimental data from surface plasmon resonance. Statistical significance differences of Rmax or EC50 were tested with Students t test (p < .05). Letter indicators signify more than 95% probability for difference of Rmax or EC50 for response via PxrAB/Tü (a), PxrTL (b), PxrSWT (c), or PxrUNK (d), whereas (*) indicates statistical significant difference between the Rmax or EC50 for CLO and 4BAB responses via the same zfPxr variant.

Table 3.

Dose-Response Dynamics for Activation of Allelic Variants of Zebrafish Pxr by CLO and 4BAB and Ligand-Receptor Interaction

Zebrafish Pxr VariantClotrimazole (CLO)
Butyl 4-Aminobenzoate (4BAB)
Rmax (e6 ΔRLU±SD)EC50 (e−7 M)Dissociation Constant (Kd) (μM)Rmax (e6 ΔRLU±SD)EC50 (e−5 M)
PxrAB/Tü22.6 ± 0.28 (b, c, d, *)1.42 (b, c, d, *)0.042.75 ± 1.65 (c, *)0.96 (b, c, *)
PxrTL34.0 ± 5.75 (a, d, *)1.08 (d, *)4.14.57 ± 2.41 (*)1.16 (a, *)
PxrSWT28.5 ± 6.80 (a, d, *)1.28 (a, *)2606.31 ± 2.86 (a, *)1.18 (a, *)
PxrUNK1.81 ± 0.67 (a, b, c)3.48 (a, b)180N/DN/D
Zebrafish Pxr VariantClotrimazole (CLO)
Butyl 4-Aminobenzoate (4BAB)
Rmax (e6 ΔRLU±SD)EC50 (e−7 M)Dissociation Constant (Kd) (μM)Rmax (e6 ΔRLU±SD)EC50 (e−5 M)
PxrAB/Tü22.6 ± 0.28 (b, c, d, *)1.42 (b, c, d, *)0.042.75 ± 1.65 (c, *)0.96 (b, c, *)
PxrTL34.0 ± 5.75 (a, d, *)1.08 (d, *)4.14.57 ± 2.41 (*)1.16 (a, *)
PxrSWT28.5 ± 6.80 (a, d, *)1.28 (a, *)2606.31 ± 2.86 (a, *)1.18 (a, *)
PxrUNK1.81 ± 0.67 (a, b, c)3.48 (a, b)180N/DN/D

Maximum response (Rmax) and effective concentration 50 (EC50) of Pxr-mediated induction of luciferase activities in COS7 cells calculated from dose-response curves fitted by nonlinear regression (GraphPad Prism 7.0). Dissociation constants were determined from experimental data from surface plasmon resonance. Statistical significance differences of Rmax or EC50 were tested with Students t test (p < .05). Letter indicators signify more than 95% probability for difference of Rmax or EC50 for response via PxrAB/Tü (a), PxrTL (b), PxrSWT (c), or PxrUNK (d), whereas (*) indicates statistical significant difference between the Rmax or EC50 for CLO and 4BAB responses via the same zfPxr variant.

Table 4.

Statistical Analysis of Luciferase Reporter Gene Responses

ACompared ResponsesPxrAB/TüPxrTLPxrSWTPxrUNK
CLODMSO vs 4.5 μM0.00010.00010.00010.0001
DMSO vs 3.0 μM0.00010.00010.00010.0001
DMSO vs 0.5 μM0.00010.00010.00010.0001
DMSO vs 83 nM0.00010.00010.00010.5961
DMSO vs 14 nM0.92310.86820.93160.9995
DMSO vs 0.2 nM0.99990.99980.99960.9971
DMSO vs 0.03 nM0.99990.99970.99980.9996
4BABDMSO vs 50 μM0.00010.00010.00010.9996
DMSO vs 33 μM0.00010.00010.00010.5488
DMSO vs 11 μM0.00010.00730.00010.9998
DMSO vs 3.7 μM0.77630.99970.9530.6689
DMSO vs 1.2 μM0.99580.99950.99950.8995
DMSO vs 0.4 μM0.99990.87960.99290.9999
DMSO vs 0.1 μM0.99940.99790.99960.993
ACompared ResponsesPxrAB/TüPxrTLPxrSWTPxrUNK
CLODMSO vs 4.5 μM0.00010.00010.00010.0001
DMSO vs 3.0 μM0.00010.00010.00010.0001
DMSO vs 0.5 μM0.00010.00010.00010.0001
DMSO vs 83 nM0.00010.00010.00010.5961
DMSO vs 14 nM0.92310.86820.93160.9995
DMSO vs 0.2 nM0.99990.99980.99960.9971
DMSO vs 0.03 nM0.99990.99970.99980.9996
4BABDMSO vs 50 μM0.00010.00010.00010.9996
DMSO vs 33 μM0.00010.00010.00010.5488
DMSO vs 11 μM0.00010.00730.00010.9998
DMSO vs 3.7 μM0.77630.99970.9530.6689
DMSO vs 1.2 μM0.99580.99950.99950.8995
DMSO vs 0.4 μM0.99990.87960.99290.9999
DMSO vs 0.1 μM0.99940.99790.99960.993
BCompared Responses0.4 nM2.3 nM14 nM83 nM0.5 μM3.0 μM4.5 μM
CLOPxrAB/Tü vs PxrTL0.01670.2374<0.0001<0.0001<0.0001<0.00010.0018
PxrAB/Tü vs PxrSWT0.77070.05110.68880.04960.02940.87250.0393
PxrAB/Tü vs PxrUNK0.89650.99980.0002<0.0001<0.0001<0.0001<0.0001
PxrTL vs PxrSWT0.15510.87740.00170.02810.00020.00070.6801
PxrTL vs PxrUNK0.00230.2755<0.0001<0.0001<0.0001<0.0001<0.0001
PxrSWT vs PxrUNK0.35480.0627<0.0001<0.0001<0.0001<0.0001<0.0001
BCompared Responses0.4 nM2.3 nM14 nM83 nM0.5 μM3.0 μM4.5 μM
CLOPxrAB/Tü vs PxrTL0.01670.2374<0.0001<0.0001<0.0001<0.00010.0018
PxrAB/Tü vs PxrSWT0.77070.05110.68880.04960.02940.87250.0393
PxrAB/Tü vs PxrUNK0.89650.99980.0002<0.0001<0.0001<0.0001<0.0001
PxrTL vs PxrSWT0.15510.87740.00170.02810.00020.00070.6801
PxrTL vs PxrUNK0.00230.2755<0.0001<0.0001<0.0001<0.0001<0.0001
PxrSWT vs PxrUNK0.35480.0627<0.0001<0.0001<0.0001<0.0001<0.0001
Compared Responses0.1 μM0.4 μM1.2 μM3.7 μM11 μM33 μM50 μM
4BABPxrAB/Tü vs PxrTL0.18400.00130.99960.42990.96370.07510.4159
PxrAB/Tü vs PxrSWT0.32290.05420.99380.95560.01750.00400.0083
PxrAB/Tü vs PxrUNK0.90710.99830.73140.10450.00110.00380.0123
PxrTL vs PxrSWT0.98750.52490.99850.18880.05700.67040.2806
PxrTL vs PxrUNK0.51650.00220.67100.84850.0002<0.00010.0001
PxrSWT vs PxrUNK0.71900.07930.57240.0322<0.0001<0.0001<0.0001

Compared Responses0.1 μM0.4 μM1.2 μM3.7 μM11 μM33 μM50 μM
4BABPxrAB/Tü vs PxrTL0.18400.00130.99960.42990.96370.07510.4159
PxrAB/Tü vs PxrSWT0.32290.05420.99380.95560.01750.00400.0083
PxrAB/Tü vs PxrUNK0.90710.99830.73140.10450.00110.00380.0123
PxrTL vs PxrSWT0.98750.52490.99850.18880.05700.67040.2806
PxrTL vs PxrUNK0.51650.00220.67100.84850.0002<0.00010.0001
PxrSWT vs PxrUNK0.71900.07930.57240.0322<0.0001<0.0001<0.0001

One-way ANOVA and Dunnett’s test were used to determine the probability that the means of responses in exposed cells were different from exposures in nonexposed/DMSO treated cells (A). One-way ANOVA and Tukey-Kramer test were used to test for statistical differences between means of responses produced by the same exposure via different zfPxr variants (B). GraphPad Prism7.0 was used for statistical analyses. Tests that returned a greater than 5% probability for equal means (p value > .05) were shaded in gray in the tables.

Table 4.

Statistical Analysis of Luciferase Reporter Gene Responses

ACompared ResponsesPxrAB/TüPxrTLPxrSWTPxrUNK
CLODMSO vs 4.5 μM0.00010.00010.00010.0001
DMSO vs 3.0 μM0.00010.00010.00010.0001
DMSO vs 0.5 μM0.00010.00010.00010.0001
DMSO vs 83 nM0.00010.00010.00010.5961
DMSO vs 14 nM0.92310.86820.93160.9995
DMSO vs 0.2 nM0.99990.99980.99960.9971
DMSO vs 0.03 nM0.99990.99970.99980.9996
4BABDMSO vs 50 μM0.00010.00010.00010.9996
DMSO vs 33 μM0.00010.00010.00010.5488
DMSO vs 11 μM0.00010.00730.00010.9998
DMSO vs 3.7 μM0.77630.99970.9530.6689
DMSO vs 1.2 μM0.99580.99950.99950.8995
DMSO vs 0.4 μM0.99990.87960.99290.9999
DMSO vs 0.1 μM0.99940.99790.99960.993
ACompared ResponsesPxrAB/TüPxrTLPxrSWTPxrUNK
CLODMSO vs 4.5 μM0.00010.00010.00010.0001
DMSO vs 3.0 μM0.00010.00010.00010.0001
DMSO vs 0.5 μM0.00010.00010.00010.0001
DMSO vs 83 nM0.00010.00010.00010.5961
DMSO vs 14 nM0.92310.86820.93160.9995
DMSO vs 0.2 nM0.99990.99980.99960.9971
DMSO vs 0.03 nM0.99990.99970.99980.9996
4BABDMSO vs 50 μM0.00010.00010.00010.9996
DMSO vs 33 μM0.00010.00010.00010.5488
DMSO vs 11 μM0.00010.00730.00010.9998
DMSO vs 3.7 μM0.77630.99970.9530.6689
DMSO vs 1.2 μM0.99580.99950.99950.8995
DMSO vs 0.4 μM0.99990.87960.99290.9999
DMSO vs 0.1 μM0.99940.99790.99960.993
BCompared Responses0.4 nM2.3 nM14 nM83 nM0.5 μM3.0 μM4.5 μM
CLOPxrAB/Tü vs PxrTL0.01670.2374<0.0001<0.0001<0.0001<0.00010.0018
PxrAB/Tü vs PxrSWT0.77070.05110.68880.04960.02940.87250.0393
PxrAB/Tü vs PxrUNK0.89650.99980.0002<0.0001<0.0001<0.0001<0.0001
PxrTL vs PxrSWT0.15510.87740.00170.02810.00020.00070.6801
PxrTL vs PxrUNK0.00230.2755<0.0001<0.0001<0.0001<0.0001<0.0001
PxrSWT vs PxrUNK0.35480.0627<0.0001<0.0001<0.0001<0.0001<0.0001
BCompared Responses0.4 nM2.3 nM14 nM83 nM0.5 μM3.0 μM4.5 μM
CLOPxrAB/Tü vs PxrTL0.01670.2374<0.0001<0.0001<0.0001<0.00010.0018
PxrAB/Tü vs PxrSWT0.77070.05110.68880.04960.02940.87250.0393
PxrAB/Tü vs PxrUNK0.89650.99980.0002<0.0001<0.0001<0.0001<0.0001
PxrTL vs PxrSWT0.15510.87740.00170.02810.00020.00070.6801
PxrTL vs PxrUNK0.00230.2755<0.0001<0.0001<0.0001<0.0001<0.0001
PxrSWT vs PxrUNK0.35480.0627<0.0001<0.0001<0.0001<0.0001<0.0001
Compared Responses0.1 μM0.4 μM1.2 μM3.7 μM11 μM33 μM50 μM
4BABPxrAB/Tü vs PxrTL0.18400.00130.99960.42990.96370.07510.4159
PxrAB/Tü vs PxrSWT0.32290.05420.99380.95560.01750.00400.0083
PxrAB/Tü vs PxrUNK0.90710.99830.73140.10450.00110.00380.0123
PxrTL vs PxrSWT0.98750.52490.99850.18880.05700.67040.2806
PxrTL vs PxrUNK0.51650.00220.67100.84850.0002<0.00010.0001
PxrSWT vs PxrUNK0.71900.07930.57240.0322<0.0001<0.0001<0.0001

Compared Responses0.1 μM0.4 μM1.2 μM3.7 μM11 μM33 μM50 μM
4BABPxrAB/Tü vs PxrTL0.18400.00130.99960.42990.96370.07510.4159
PxrAB/Tü vs PxrSWT0.32290.05420.99380.95560.01750.00400.0083
PxrAB/Tü vs PxrUNK0.90710.99830.73140.10450.00110.00380.0123
PxrTL vs PxrSWT0.98750.52490.99850.18880.05700.67040.2806
PxrTL vs PxrUNK0.51650.00220.67100.84850.0002<0.00010.0001
PxrSWT vs PxrUNK0.71900.07930.57240.0322<0.0001<0.0001<0.0001

One-way ANOVA and Dunnett’s test were used to determine the probability that the means of responses in exposed cells were different from exposures in nonexposed/DMSO treated cells (A). One-way ANOVA and Tukey-Kramer test were used to test for statistical differences between means of responses produced by the same exposure via different zfPxr variants (B). GraphPad Prism7.0 was used for statistical analyses. Tests that returned a greater than 5% probability for equal means (p value > .05) were shaded in gray in the tables.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close